MZ
Publicaties op Oncologisch.com
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as eerstelijns treatment for gevorderd squamous n...
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blin...
Ivonescimab plus chemotherapie bij EGFR-variant NSCLC: fase II
Perioperatieve toripalimab plus chemotherapie bij resectabel NSCLC: Neotorch fase III
Bempegaldesleukin plus nivolumab bij onbehandeld melanoom: PIVOT IO 001 fase III